The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus

Balanced control of neuronal activity is central in maintaining function and viability of neuronal circuits. The endocannabinoid system tightly controls neuronal excitability. Here, we show that endocannabinoids directly target hippocampal glutamatergic neurons to provide protection against acute epileptiform seizures in mice. Functional CB1 cannabinoid receptors are present on glutamatergic terminals of the hippocampal formation, colocalizing with vesicular glutamate transporter 1 (VGluT1). Conditional deletion of the CB1 gene either in cortical glutamatergic neurons or in forebrain GABAergic neurons, as well as virally induced deletion of the CB1 gene in the hippocampus, demonstrate that the presence of CB1 receptors in glutamatergic hippocampal neurons is both necessary and sufficient to provide substantial endogenous protection against kainic acid (KA)-induced seizures. The direct endocannabinoid-mediated control of hippocampal glutamatergic neurotransmission may constitute a promising therapeutic target for the treatment of disorders associated with excessive excitatory neuronal activity.

[1]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[2]  A. Hoffman,et al.  Species and strain differences in the expression of a novel glutamate‐modulating cannabinoid receptor in the rodent hippocampus , 2005, The European journal of neuroscience.

[3]  M. Klugmann,et al.  AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats , 2005, Molecular and Cellular Neuroscience.

[4]  E. Simpson,et al.  Using conditional mutagenesis to study the brain , 2003, Biological Psychiatry.

[5]  K. Nave,et al.  Hippocampal cGMP-Dependent Protein Kinase I Supports an Age- and Protein Synthesis-Dependent Component of Long-Term Potentiation But Is Not Essential for Spatial Reference and Contextual Memory , 2003, The Journal of Neuroscience.

[6]  George Kunos,et al.  Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus , 2001, Neuron.

[7]  Ivan Soltesz,et al.  Mossy cells in epilepsy: rigor mortis or vigor mortis? , 2002, Trends in Neurosciences.

[8]  K. Nave,et al.  NEX-1: a novel brain-specific helix-loop-helix protein with autoregulation and sustained expression in mature cortical neurons , 1994, Mechanisms of Development.

[9]  S. Anderson,et al.  Origin and Molecular Specification of Striatal Interneurons , 2000, The Journal of Neuroscience.

[10]  L. Petrocellis,et al.  The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.

[11]  A. Berns,et al.  Cre-mediated somatic site-specific recombination in mice. , 1997, Nucleic acids research.

[12]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[13]  K. Rajewsky,et al.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.

[14]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[15]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[16]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[17]  G. Shepherd.  The Synaptic Organization of the Brain , 1979 .

[18]  Caiying Guo,et al.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon cre‐mediated excision , 2000, Genesis.

[19]  P. Somogyi,et al.  The hippocampal CA3 network: An in vivo intracellular labeling study , 1994, The Journal of comparative neurology.

[20]  L. Petrocellis,et al.  The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.

[21]  J. Li,et al.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. , 2002, Molecular endocrinology.

[22]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[23]  Ken Mackie,et al.  Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.

[24]  K. Nicolay,et al.  Acute neuronal injury, excitotoxicity, and the endocannabinoid system , 2002, Molecular Neurobiology.

[25]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[26]  M. Elphick,et al.  Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1 , 2000, The Journal of comparative neurology.

[27]  F. Fujiyama,et al.  Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain , 2002, The Journal of comparative neurology.

[28]  D. Lovinger,et al.  Emerging roles for endocannabinoids in long‐term synaptic plasticity , 2003, British journal of pharmacology.

[29]  K. Mackie,et al.  Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation , 1999, Neuroscience.

[30]  M. Ekker,et al.  A Highly Conserved Enhancer in the Dlx5/Dlx6Intergenic Region is the Site of Cross-Regulatory Interactions betweenDlx Genes in the Embryonic Forebrain , 2000, The Journal of Neuroscience.

[31]  B. Lutz.  On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. , 2004, Biochemical pharmacology.

[32]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[33]  M. Ekker,et al.  Expression from a Dlx gene enhancer marks adult mouse cortical GABAergic neurons. , 2002, Cerebral cortex.

[34]  K. Mackie,et al.  Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.

[35]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.

[36]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[37]  Angel Amores,et al.  Regulatory roles of conserved intergenic domains in vertebrate Dlx bigene clusters. , 2003, Genome research.

[38]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[39]  Y. Ben-Ari,et al.  Kainate, a double agent that generates seizures: two decades of progress , 2000, Trends in Neurosciences.

[40]  K. Mackie,et al.  A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain , 1999, Neuroscience.

[41]  R. Fremeau,et al.  VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate , 2004, Trends in Neurosciences.

[42]  M. Frotscher,et al.  Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus , 2000, The Journal of Neuroscience.

[43]  C. Lobe,et al.  Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.

[44]  G. Marsicano,et al.  Neuromodulatory functions of the endocannabinoid system. , 2006, Journal of endocrinological investigation.

[45]  I. Soltesz,et al.  Presynaptic, Activity-Dependent Modulation of Cannabinoid Type 1 Receptor-Mediated Inhibition of GABA Release , 2006, The Journal of Neuroscience.

[46]  B. Alger.  Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids , 2002, Progress in Neurobiology.

[47]  T. Bonner,et al.  Localization of cannabinoid receptor mRNA in rat brain , 1993, The Journal of comparative neurology.

[48]  O. Steward,et al.  Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Ben-Shabat,et al.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury , 2001, Nature.

[50]  J. Fritschy,et al.  A new benzodiazepine pharmacology. , 2002, The Journal of pharmacology and experimental therapeutics.

[51]  Y. Ueta,et al.  Induction of Pituitary Adenylate Cyclase-Activating Polypeptide mRNA in the Medial Parvocellular Part of the Paraventricular Nucleus of Rats following Kainic-Acid-Induced Seizure , 2000, Neuroendocrinology.

[52]  T. Freund,et al.  Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus , 2001, Neuroscience.

[53]  R. Spencer,et al.  Immunohistochemical localization of the neural cannabinoid receptor in rat brain , 1998, Journal of neuroscience research.

[54]  A. Schierloh,et al.  Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission , 2006, The Journal of Neuroscience.

[55]  Minjeong Kang,et al.  Differential changes of calcium binding proteins in the rat striatum after kainic acid-induced seizure , 2002, Neuroscience Letters.

[56]  Masahiko Watanabe,et al.  The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynaptic Sites in the Hippocampus and Cerebellum , 2006, The Journal of Neuroscience.

[57]  W. Precht.  The synaptic organization of the brain G.M. Shepherd, Oxford University Press (1975). 364 pp., £3.80 (paperback) , 1976, Neuroscience.

[58]  Ken Mackie,et al.  Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.

[59]  M. Mazzuferi,et al.  Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study , 2004, Journal of neurochemistry.

[60]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[61]  K. Mackie,et al.  Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input‐specific retrograde signalling by cholinergic neurons , 2003, The European journal of neuroscience.

[62]  KouichiC . Nakamura,et al.  Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[64]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[65]  P. Castillo,et al.  The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus , 2006, Neuroscience.

[66]  Philip R. Johnson,et al.  Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. , 1999, Human gene therapy.

[67]  J. Feldon,et al.  Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain , 2000, Gene Therapy.